Tuesday, August 3, 2010

Pfizer: Strong Q2 Earnings Beat Analysts' Estimates

Today, Pfizer (NYSE: PFE) announced their 2Q 2010 earnings.  Earnings per share amounts to US$0.62, 10 cents higher than the expected 52 cents EPS.  It is also higher than the 48 cents EPS a year ago.  This is positive development for Pfizer after the inverted head & shoulders bullish chart pattern being observed at Pfizer's price chart in this blog entry.  

The stock price jumped 3.55% at US$16.05 at market open.  It is good development, but don't be overjoyed.  When a stock's price goes euphoric, it is time to keep your eyes wide open and find out ways to hedge against any adverse developments.

Happy investing!

No comments:

Post a Comment